NCT03269617View on ClinicalTrials.gov

PHAGE Study: Bacteriophages as Novel Prebiotics

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

May 30, 2017

Conditions
Gastrointestinal Disorder, Functional
Interventions
DIETARY_SUPPLEMENT

Bacteriophage mixture

Four bacteriophage strains: LH01-Myoviridae, LL5-Siphoviridae, T4D-Myoviridae, and LL12-Myoviridae.

OTHER

Placebo Control

Placebo control capsule consisting of rice maltodextrin

Sponsors

Collaborators (1)

Metabiomics Corp
All Listed Sponsors
collaborator

George Mason University

OTHER

collaborator

Metabiomics Corp

INDUSTRY

lead

Colorado State University

OTHER

NCT03269617 - PHAGE Study: Bacteriophages as Novel Prebiotics | Biotech Hunter | Biotech Hunter